Ruxolitinib Plus Decitabine Effectively Treats Myelodysplastic Syndrome/Myeloproliferative Neoplasm, Unclassifiable, by Decreasing the Variant Allele Frequency of KRAS
Shuna Luo,1 Xiaofei Xu,1 Xingnong Ye,1,2 Xiaoqiong Zhu,1 Cai Wu,1 Dan Chen,1 Jingxia Jin,1 Yan Zheng,1 Mengli Zheng,1 Jian Huang1,2 1Department of Hematology, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, Zhejiang, People’s Republic of China; 2Department o...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-10-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/ruxolitinib-plus-decitabine-effectively-treats-myelodysplastic-syndrom-peer-reviewed-article-OTT |